https://www.selleckchem.com/pr....oducts/afuresertib-g
Aims In Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), electrophysiological pathology has been claimed to precede morphological and functional pathology. Accordingly, an ECG without ARVC markers should be rare in ARVC patients with pathology identified by cardiac imaging. We quantified the prevalence of ARVC patients with evidence of structural disease, yet without ECG Task Force Criteria (TFC). Methods and results We included 182 probands and family members with ARVC-associated mutations (40 ± 17 years, 50% wome
Aimer
Commentaire
Partagez
